×
About 15,860 results

ALLMedicine™ Pulmonary Fibrosis Center

Research & Reviews  5,316 results

Inflammatory bowel disease and risk of idiopathic pulmonary fibrosis: A protocol for sy...
https://doi.org/10.1371/journal.pone.0270297
PloS One; Wang J, Kou F et. al.

Jun 25th, 2022 - Inflammatory bowel disease is a relapsing chronic gastrointestinal inflammatory disease. Idiopathic pulmonary fibrosis is a rare but serious extraintestinal pulmonary manifestation of inflammatory bowel disease. However, the relationship between t...

Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulm...
https://doi.org/10.1097/MCP.0000000000000876
Current Opinion in Pulmonary Medicine; Spagnolo P, Semenzato U

Jun 25th, 2022 - Growing evidence suggests that ageing-associated alterations occur in both idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). Here, we review the most recent literature on dysregulated ageing pathways in IPF and ...

Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
https://clinicaltrials.gov/ct2/show/NCT02315586

Jun 24th, 2022 - Idiopathic Pulmonary Fibrosis (IPF) is a chronic progressive disease that occurs primarily in older individuals, 55 to 75 years of age, with a median survival of approximately 3 years from time of diagnosis. At present, there are no effective trea...

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
https://clinicaltrials.gov/ct2/show/NCT02327897

Jun 24th, 2022 - This study will be a prospective, longitudinal, observational, single-center, exploratory, natural history study to collect samples and data that will enable prospective explorations of the interaction between environmental exposures and disease p...

Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
https://clinicaltrials.gov/ct2/show/NCT00001456

Jun 24th, 2022 - Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disease consisting of oculocutaneous albinism, a platelet storage pool defect and, in some patients, lysosomal accumulation of ceroid lipofuscin. Other manifestations include pulmonary ...

see more →

Guidelines  8 results

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults:...
https://doi.org/10.1164/rccm.202202-0399ST
American Journal of Respiratory and Critical Care Medicine; Raghu G, Remy-Jardin M et. al.

Apr 30th, 2022 - Background: This American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior idiopathic pulmonary fibrosis (IPF) guidelines and addresses the progression of...

The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fib...
https://doi.org/10.1016/j.chest.2022.03.023
Chest Newton CA, Oldham JM et. al.

Mar 27th, 2022 - Patients with familial pulmonary fibrosis represents a subset of patients with pulmonary fibrosis in whom inherited gene variation predisposes them to disease development. In the appropriate setting, genetic testing allows for personalized assessm...

Exercise and sports after COVID‐19—Guidance from a clinical perspective
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250714/
Translational Sports Medicine; Halle M, Bloch W et. al.

May 4th, 2021 - SARS‐CoV‐2 infection has emerged as not only a pulmonary but also potentially multi‐organ disease, which may cause long‐term structural damage of different organ systems including the lung, heart, vasculature, brain, liver, kidney, or intestine. A...

S2K Guideline for Diagnosis of Idiopathic Pulmonary Fibrosis.
https://doi.org/10.1159/000512315
Respiration; International Review of Thoracic Diseases; Behr J, Günther A et. al.

Jan 25th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease. Diagnosis of IPF requires considerable expertise and experience. Since the publication of the international IPF guideline in the year 2011 and the update 2018 several studies...

Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic ...
https://doi.org/10.5603/ARM.2020.0081
Advances in Respiratory Medicine; Piotrowski WJ, Bestry I et. al.

Mar 11th, 2020 - This document presents the guidelines of the Polish Respiratory Society (PTChP, Polskie Towarzystwo Chorób Płuc) for diagnosis and treatment of idiopathic pulmonary fibrosis (IPF), developed by agroup of Polish experts. The recommendations were de...

see more →

Drugs  31 results see all →

Clinicaltrials.gov  579 results

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-...
https://clinicaltrials.gov/ct2/show/NCT04702893

Jun 24th, 2022 - The primary objective of this observational study is to investigate the correlation between changes from baseline at 52 weeks in forced vital capacity (FVC) and changes from baseline at 52 weeks in dyspnea score points or cough score points as mea...

An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options
https://clinicaltrials.gov/ct2/show/NCT04739150

Jun 24th, 2022 - This Expanded Access Program in Belgium is open to people with different lung diseases. This program provides a medicine called nintedanib to people who have no alternative treatment options. They can participate if they have a type of lung diseas...

Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
https://clinicaltrials.gov/ct2/show/NCT02315586

Jun 24th, 2022 - Idiopathic Pulmonary Fibrosis (IPF) is a chronic progressive disease that occurs primarily in older individuals, 55 to 75 years of age, with a median survival of approximately 3 years from time of diagnosis. At present, there are no effective trea...

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
https://clinicaltrials.gov/ct2/show/NCT02327897

Jun 24th, 2022 - This study will be a prospective, longitudinal, observational, single-center, exploratory, natural history study to collect samples and data that will enable prospective explorations of the interaction between environmental exposures and disease p...

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis
https://clinicaltrials.gov/ct2/show/NCT05185089

Jun 24th, 2022 - The study will be a multi-center, double-blind, randomised, placebo-controlled 2-period cross-over study in subjects with chronic cough due to idiopathic pulmonary fibrosis (IPF). Subjects will participate in one of two cohorts (Cohort 1 and Cohor...

see more →

News  397 results

Fast Five Quiz: Idiopathic Pulmonary Fibrosis Imaging
https://reference.medscape.com/viewarticle/925458

Jun 21st, 2022 - Idiopathic pulmonary fibrosis (IPF) is a rare form of chronic, progressive fibrosing interstitial pneumonia of unknown etiology. Global incidence and prevalence of IPF are between 0.09 and 1.30 per 10,000 people, according to Mei and colleagues. I...

Fast Five Quiz: Progressive Fibrosing Interstitial Lung Disease Presentation and Diagnosis
https://reference.medscape.com/viewarticle/946214

Jun 16th, 2022 - Progressive fibrosing interstitial lung diseases (PF-ILD) are a heterogeneous group of interstitial lung diseases clinically characterized by accelerated respiratory failure, frequent disease exacerbation, decreased quality of life, and earlier mo...

Fast Five Quiz: Progressive Fibrosing Interstitial Lung Disease Presentation and Diagnosis
https://www.medscape.com/viewarticle/946214

Jun 16th, 2022 - Progressive fibrosing interstitial lung diseases (PF-ILD) are a heterogeneous group of interstitial lung diseases clinically characterized by accelerated respiratory failure, frequent disease exacerbation, decreased quality of life, and earlier mo...

Living and leading with lung disease
https://www.mdedge.com/chestphysician/article/255339/society-news/living-and-leading-lung-disease

Jun 13th, 2022 - Receiving a chronic disease diagnosis can be paralyzing, with a wide range of associated emotions. A patient’s family, physicians, and other health care professionals can provide a source of support, but, often, the strongest support comes from th.

Does Viagra reduce mortality in pulmonary fibrosis?
https://www.mdedge.com/chestphysician/article/254988/pulmonology/does-viagra-reduce-mortality-pulmonary-fibrosis
Pam Harrison, MDedge News

May 26th, 2022 - Sildenafil (Viagra, Pfizer), a phosphodieterase-5 (PDE-5) inhibitor and a pulmonary-selective vasodilator, may reduce mortality in patients with idiopathic pulmonary fibrosis (IPF), compared with placebo or standard of care but it does not reduce.

see more →

Patient Education  13 results see all →